smart camera instantly shows how blood is flowing through vessels during surgery
Currently, surgical teams have limited options – inject dye or attach ultrasound probe
Options
DYE
Is there flow?
yes
PROBE
How much flow?
70 ml/min
VIEWFLOW
How is it flowing?
←70ml/min3x←70ml/minrecirculating↑ stagnant
Smart camera – no contact:
Instantly see how blood flows, whenever needed
After seeing this level of information, it would be difficult to operate without it.
— Chief Heart Surgeon, Dr. Theodoro
Who would want to visualize flow through graft and coronary for obstructive disease—on the table—after cross-clamp—before coming off pump?
A near unanimous response!
21st Century Cardiothoracic Surgical Society | Palm Beach meeting
Repeat Novadaq’s playbook & performance:
- Same surgeons, same workflow, but without dye
- 50%+ sales growth
- Company valuation of $350M to $792M ($23M to $35M Sales)
Chart Year 2-3, skips 3-year U.S. financial / housing crisis
Jim Sund, PhD, CEO/CTO
NASA Fellow | Commercialized health-tech to Roche & Merck
Proven Path to Market Exit
Randall Wolf, MD
Houston Methodist, DeBakey Heart & Vascular Center
Data‑driven wins
Kimberly Steinmann, MD
Clinical Studies Lead Advisor
Relevant to many surgeries
Dennis Robbins, PhD, M.P.H.
Chief Strategy & Payment Advisor and National Thought Leader
Could change the Standard of Care
Engaging with leading academic medical centers to help reduce patient complications and costs and become a future standard of care
What investors are saying
I love knowing my money helps real people recover faster and return to active living.
ViewFlow may well change the standard of care.
Investing in ViewFlow was easy and exciting.
For you, it’s a chance to back something meaningful with real clinical and financial upsides.
$4.5M invested of $5M raise
as cash and IRAs